| 1 | Evaluation of the role of vitamin D receptors (VDR) polymorphisms on the efficacy of calcitriol therapy in stage 3-5 chronic kidney disease (CKD): A prospective double-blind study | Dr. Sudip Kr. Datta | ICMR | 3Yrs | 2021-2024 | Rs. 53,97,494/- (Fifty three lakhs ninety seven thousand four hundred and ninety four rupees only) |
| 2 | Long Term Effects of COVID-19 on endocrine system, semen quality and sperm proteome | Dr. Sudip Kr. Datta | AIIMS – IMRG Collaborative Research Project | 3Yrs | 2021-2023 | Rs. 20,00,000/- (Twenty lakhs only) |
| 3 | Development of Opto-electronic sensor for point-of-care diagnostics of micro-albumin in urine sample | Dr. Sudip Kr. Datta | AIIMS – IIT Delhi Collaborative Research Project | 2Yrs (Extended for 6 months) | 2019-2022 | Rs. 20,00,000/- (Twenty lakhs only) overall |
| 4 | Characterization and expression of transfer RNA derived small RNAs as a circulating biomarker for disease diagnosis and prognosis in NAFLD | Dr. Shyam Prakash | ICMR | 3 Years | 2022-2025 | Rs. 55.5 Lakh |
| 5 | Molecular interaction of iron trafficking gene variants with mitochondrial dysfunction in metabolically associated fatty liver disease | Dr. Shyam Prakash | ICMR | 3 Years | 2022-2025 | Rs. 52.5 Lakhs |
| 6 | Molecular coordination of T-regulatory cells and Prokineticins in obesity and their clinical correlation in obesity associated inflammation in non alcoholic fatty liver disease and metabolic syndrome | Dr. Shyam Prakash | ICMR | 2 years | 2021-2023 | Rs. 52.5 Lakh |
| 7 | An expensive and rapid diagnostic method for detection of SARS COV-2 and COVID-19 RNA by loop mediated isothermal amplification (LAMP) | Dr. Shyam Prakash | Intramural AIIMS | 2 years | 2020-2022 | Rs. 10 Lakh |
| 8 | Rapid diagnostic evaluation of Micro PCR for Hepatitis B virus DNA quantitation | Dr. Shyam Prakash | BigTech Bangalore | 5 Years | 2017-2022 | Rs. 40.0 Lakh |
| 9 | Development and validation of Standalone meter for non invasive salivary glucose quantification | Dr. Shyam Prakash | BIRAC (DST) | 2 years | 2021-2022 | Rs. 10.0 Lakh |
| 10 | Saliva as an alternate specimen source for SARs-COV-2 in symptomatic patients using Cepheid Xpert Xpress SARS-COV-2 in an outpatient setting | Dr. Suneeta Meena | AIIMS, DELHI | 1.5 years | 2020-2022 | Rs. 8,80,000 |
| 11 | Triacetylfusarinine C (TAFC) as a potential biomarker for early diagnosis of invasive aspergillosisin patients with haematological malignancy | Dr. Suneeta Meena | AIIMS, DELHI | 2 years | 2021-2023 | Rs. 4.40,000 |
| 12 | Evaluation of Artificial neural network for differentiating Iron deficiency anemia and β-Thalassemia trait in comparison to the conventional methods | Dr. Tushar Sehgal | ICMR, INDIA | 2 years | 2022-2023 | Rs. 22,87,766 |
| 13 | Evaluation of Extended inflammatory parameters of activated neutrophils (NEUT-RI, NEUT-GI), immature granulocytes (IG), reactive lymphocytes (RE-LYMP) and T cell-independent plasma cells (AS-LYMP) in Pyrexia of unknown origin and its correlation with functional imaging and conventional inflammatory parameters | Dr. Tushar Sehgal | SYSMEX, INDIA | 1 year | 2022-2023 | Rs. 13,36,500 |
